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that can mimic early symptoms of TB;2,5,6 the nature 
of pulmonary TB (PTB) disease in HIV-infected people, 
which often renders sputum smear microscopy (the 
most commonly available diagnostic tool in resource-
limited settings) negative;7 and the fear of use of chest 
radiography (CXR) in pregnancy due to concerns re-
garding radiation-induced teratogenicity.5 
Symptom screening is recommended to identify TB 
suspects in HIV-infected populations,8 including preg-
nant women,9 but it has not been evaluated in HIV-
i  nfected pregnant women. The study populations of 
the two most recent published studies, Cain et al. and 
Corbett et al., were composed of HIV-infected adult pa-
tients but were not stratiﬁ  ed with regard to pregnancy 
status.10,11 Similarly, in a meta-analysis of observational 
studies there was no stratiﬁ  cation based on pregnancy 
status.8 As such these results may not be applicable to 
the HIV-infected pregnant population. In a PMTCT pro-
gram in western Kenya, access to clinical laboratory 
services and CXR allowed for in-depth investigations 
into the role of symptom screening in HIV-infected 
pregnant women. 
The aim of this study was to determine the diagnos-
tic usefulness of symptom screening for TB in detect-
ing active PTB among HIV-infected pregnant women 
in two PMTCT clinics in western Kenya. This was a de-
scriptive analysis of women who were positive or neg-
ative on symptom screening to compare demograph-
ics, sputum results, CXR results and TB diagnosis. 
METHODS
Study design
This was a cross-sectional analysis of data.
Setting
The study was carried out in two Government of K  enya 
PMTCT clinics, Eldoret and Busia in western Kenya, 
which are supported by the Academic Model Provid-
ing Access to Healthcare (AMPATH) partnership.12–14 
These two sites were chosen because they represented 
the busiest PMTCT programs in AMPATH (on aver-
age 30 patients each per month), both had access to 
a quality-controlled TB laboratory, were capable of 
smear microscopy and rapid culture (Mycobacteria 
Growth Indicator Tube), and both sites had functional 
CXR, with appropriate shielding for pregnant women. 
This study took place between 1 October 2009 and 
28 February 2010.
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Objective: To determine the diagnostic usefulness of tu-
berculosis (TB) symptom screening to detect active pul-
monary TB among human immunodeficiency virus (HIV) 
infected pregnant women in two PMTCT (prevention of 
mother-to-child transmission) clinics in western Kenya 
that are supported by the United States Agency for Inter-
national Development–Academic Model Providing Access 
to Healthcare partnership.
Design: Cross-sectional study. Participants were inter-
viewed for TB symptoms with a standardized question-
naire (cough >2 weeks, fever, night sweats, weight loss or 
failure to gain weight). Those with cough submitted spu-
tum specimens for smear microscopy for acid-fast bacilli 
and mycobacterial culture. Women at >14 weeks gesta-
tion underwent shielded chest radiography (CXR). 
Results: Of 187 HIV-infected women, 38 (20%) were 
symptom screen-positive. Of these, 21 had a cough for 
>2 weeks, but all had negative sputum smears and my-
cobacterial cultures. CXRs were performed in 26 symp-
tomatic women: three were suggestive of TB (1 miliary, 
1 infiltrates and 1 cavitary). Of 149 women with a nega-
tive symptom screen, 100 had a CXR and seven had a CXR 
suggestive of TB (1 cavitary, 2 miliary and 4 infiltrates). 
Conclusion: This study did not support the utility of iso-
lated symptom screening in identification of TB disease in 
our PMTCT setting. CXR was useful in identification of TB 
suspects in both symptomatic and asymptomatic women.
D
espite the fact that tuberculosis (TB) is the most 
common opportunistic infection in persons liv-
ing with HIV/AIDS (human immunodeﬁ  ciency virus/
acquired immune-deﬁ  ciency syndrome), as well as a 
signiﬁ  cant cause of maternal mortality and morbid-
ity in this group, screening is not routinely done in 
PMTCT (prevention of mother-to-child transmission) 
settings.1–4 This omission is likely related to clinician-
perceived urgency in initiating antiretroviral therapy 
(ART), coupled with the challenges inherent in the 
screening process for active TB in HIV-infected preg-
nant women. 
The challenges of PMTCT ART initiation have been 
well addressed, with the establishment of programs 
throughout the world. However, the challenges related 
to screening for TB remain unaddressed in any system-
atic approach. This population represents its own chal-
lenges: the non-speciﬁ   c nature of early pregnancy 
symptoms (such as frequency of malaise and fatigue) 
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Participants and sample
Study participants were newly enrolled (i.e., ART na-
ïve), HIV-infected pregnant women aged 15–49 years 
who attended the two selected PMTCT clinics. Those 
already on TB treatment at the time of enrolment or 
with a past history of isoniazid preventive therapy (IPT) 
were excluded. Convenience sampling was used at 
weekly clinic visits over the 5-month study period, en-
rolling all consecutive eligible women until the sample 
size was obtained (n = 187). Sample size was calcu-
lated using 12.5% as the expected prevalence of TB in 
HIV-infected pregnant women, with 80% power, yield-
ing a sample of 187.15 
Study procedure 
All study participants were interviewed by the primary 
researcher regarding demographic variables and current 
symptoms: cough for >2 weeks, fever, night sweats, 
weight loss or failure to gain weight. The standardized 
symptom screen questionnaire used was developed and 
standardized in Kenya at multiple sites in the late 1990s, 
and has been used extensively in an intensiﬁ  ed case 
ﬁ  nding program for TB in western Kenya. Although not 
speciﬁ  cally standardized for studies in HIV-infected in-
dividuals, its broad use in our region has provided staff 
with a degree of familiarity in its use.
Patients with a positive symptom screen that in-
cluded the presence of cough were asked to supply two 
sputum specimens (one spot and one morning) to be 
sent for smear microscopy and TB culture. All smear 
microscopy and TB cultures were sent to the regional 
reference laboratory, which is ISO (International Orga-
nization for Standardization) 15 189 certiﬁ  ed as adher-
ing to international harmonization standards for good 
laboratory practice. Smear was performed on uncon-
centrated sputum. Specimens were pooled for culture. 
Women post 14 weeks gestation underwent shielded 
CXR with their permission. All CXRs were read by a 
single consultant radiologist.
Outcome variables 
TB diagnosis was deﬁ  ned as conﬁ  rmed if either smear 
or culture was positive, and presumptive if the CXR 
was interpreted as suggestive of TB (cavitary, miliary 
pattern or inﬁ  ltrate). All patients diagnosed with either 
conﬁ  rmed or presumptive TB disease were referred back 
to their care providers for management, according to 
the hospital protocols.
Ethics
The study had the ethical approval of the Moi Teach-
ing and Referral Hospital/Moi University School of 
Medicine Institutional Research and Ethics Committee 
and the Ethics Advisory Group of the International 
Union Against Tuberculosis and Lung Disease. 
RESULTS
A total of 187 HIV-infected pregnant women attend-
ing our PMTCT clinics were included in the study, of 
whom 38 (20%) were symptom screen-positive. Their 
characteristics are summarized in Table 1. The mean age 
of the participants was 27 years. There were no signiﬁ  -
cant differences in age, educational level, employment 
status, parity, CD4 count at enrolment or gestational 
age between patients with and without TB symptoms. 
Patients’ HIV was not advanced, as shown by a mean 
CD4 count of >450 cells/μl in both groups.
Results of the diagnostic screening are shown in 
the Figure. Of the 38 patients with a positive symptom 
screen, 21 had had a cough for >2 weeks. Sputum 
samples were collected from those patients: all were 
TB smear- and culture-negative. CXR was offered to 
all women who were at >14 weeks’ gestation. In the 
symptomatic group, 26 CXRs were performed, of which 
three were suggestive of TB (1 miliary, 1 inﬁ  ltrative, 
1 cavitary). Of 149 women with a negative symptom 
screen, 100 consented; of these, seven had a CXR sug-
gestive of TB (2 miliary, 4 inﬁ  ltrative, 1 cavitary). 
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TABLE 1  Characteristics of HIV-infected pregnant 
women screened for TB in a PMTCT program in western 
Kenya, 2009–2010
Variable
Positive 
symptom 
screen
(n = 38)
n (%) or
mean ± SD
Negative 
symptom 
screen
(n = 149)
n (%) or
mean ± SD P value
Age, years   27 ± 6   27 ± 6 0.7
Educational level 
 Primary
 Secondary
 College/university
 Unknown
25 (66)
 8  (21)
 0
 5  (13)
104 (70)
 27  (18)
  3  (2)
 15  (10)
0.8
Employed   6  (16)  27  (18) 0.7
Parity   3  ±  2   2  ± 2 0.3
CD4 counts, cells/μl  452 ± 246 497 ± 285 0.6
Gestational age, weeks   27 ± 7   26 ± 7 0.6
HIV = human immunodeficiency virus; TB = tuberculosis; PMTCT = 
prevention of mother-to-child transmission; SD = standard deviation.
FIGURE  Results of symptom screening for TB in HIV-i  nfected pregnant women 
in a PMTCT program in western Kenya, 2009–2010. CXR = chest X-ray; AFB = 
acid-fast bacilli; TB = tuberculosis; HIV = human immuno  deficiency virus; PMTCT = 
prevention of mother-to-child transmission.Public Health Action TB symptom screening in PMTCT clinics  3
In all 10 patients with CXRs suggestive of TB (three with posi-
tive symptom screen and seven without), there was no correla-
tion between symptoms and r  adiographic patterns, age and CD4 
counts (Table 2). All 10 patients were evaluated by their care pro-
vider and initiated on TB treatment according to both national 
and AMPATH guidelines. 
DISCUSSION
This study examined the utility of symptom screening in HIV-
i  nfected pregnant women combined with sputum TB smear, TB 
culture and CXR. The symptom screening tool failed to detect TB 
in this population. Of 26 symptomatic patients who underwent 
CXR, only three had abnormal CXRs consistent with TB and none 
had positive smears, while seven of 100 asymptomatic patients 
who underwent CXR were treated for TB.  
This is a disappointing ﬁ  nding, as it was hoped that a ques-
tionnaire screening tool might assist in guiding targeting speciﬁ  c 
subpopulations for further TB screening in pregnancy. Reliance 
on TB symptom screening alone in HIV-infected pregnant women 
in our setting was thus not helpful in deciding who should re-
ceive the next level of TB screening (in our setting a CXR). 
Our symptom screen ﬁ  ndings are similar to those in a study of 
370 HIV-infected pregnant women in a PMTCT clinic, Soweto, 
South Africa, also with high CD4 counts. That study discovered a 
similar rate of symptom screen-positive HIV-infected pregnant 
women; 120 (32%) were symptomatic by screen, and eight were 
diagnosed with TB by culture.4 That study did not perform CXRs 
among symptomatic or asymptomatic women.
CXR did discover abnormalities in this patient population, in 
both symptomatic and asymptomatic individuals, and thus may 
be an important tool in this group. A limitation of this sugges-
tion, however, is that these women could only be classiﬁ  ed as pre-
sumptive TB, as no symptomatic women were conﬁ  rmed by TB 
culture, and asymptomatic women did not undergo culture. This 
meant that sensitivity, speciﬁ  city and predictive values could not 
be calculated. 
This study suggests that reliance solely on symptom screening 
to diagnose TB in HIV-infected pregnant women in settings such 
as ours is insufﬁ  cient for either making or ruling out a diagnosis 
of TB. The evidence from this study is that symptom screening in 
our setting needs to be coupled with CXR to access the need for 
drug treatment for TB disease or IPT. Further studies of both HIV-
infected and non-infected pregnant populations with different TB 
burdens are required. A diagnosis of TB has outcome implications 
for both mother and child. The barriers intrinsic to studies in this 
vulnerable patient population should be addressed to design sci-
entiﬁ  cally evaluated guidelines for their care. 
A strength of this study is that symptom screening was applied 
in a standardized manner, under routine program conditions, that 
would be applicable to other PMTCT care programs. This study 
also had access to a quality-controlled TB laboratory, functional 
radiology units and a consultant radiologist. Finally, the observa-
tional study adhered to STROBE (Strengthening the Reporting of 
Observational Studies in Epidemiology) guidelines.16 
In conclusion, this study did not support the utility of isolated 
symptom screening in the identiﬁ   cation of TB disease in our 
PMTCT setting. CXR was useful in the identiﬁ  cation of TB sus-
pects in both symptomatic and asymptomatic women. Given the 
profound risks of TB to the HIV-infected pregnant woman and her 
infant, further well-designed studies targeted at best TB screening 
practices in this speciﬁ  c population are needed.
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TABLE 2  Clinical details for 10 patients with chest radiographs 
suggestive of TB in a PMTCT program in western Kenya, 2009–2010
Chest X-ray
TB symptom 
screen 
Age 
years 
CD4 count 
cells/μl
Miliary Positive 25   36
Infiltrate Positive 35 499
Cavity Positive 25 436
Infiltrate Negative 23 179
Infiltrate Negative 22 254
Infiltrate Negative 39 232
Infiltrate Negative 32 407
Military Negative 27 315
Cavity Negative 24 199
Military Negative 36 373
TB = tuberculosis; PMTCT = prevention of mother-to-child transmission.Public Health Action TB symptom screening in PMTCT clinics  4
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Objectif  :    Déterminer l’utilité diagnostique du dépistage des symp-
tômes de la tuberculose (TB) pour la détection d’une TB pulmonaire 
active parmi les femmes enceintes séropositives pour le VIH dans 
deux polycliniques (PMTCT) de prévention de la transmission du VIH 
mère-à-enfant soutenues par le partenariat USAID–AMPATH dans 
l’ouest du Kenya.
Schéma  :    Étude transversale. Les participants ont été interviewés 
concernant les symptômes TB en utilisant un questionnaire standar-
disé (toux depuis >2 semaines, sueurs nocturnes, perte ou échec de 
gain de poids). Les femmes qui toussaient ont donné deux échan-
tillons de crachats pour l’examen microscopique des frottis à la re-
cherche de bacilles acido-résistants et pour la culture. Les femmes en-
ceintes de >14 semaines ont subi un cliché thoracique (CXR) avec 
écran protecteur. 
Résultats  :  Sur les 187 femmes séropositives pour le VIH, le dépistage 
des symptômes a été positif chez 38 (20%) ; parmi ces dernières, 
21 toussaient depuis >2 semaines mais chez toutes les frottis et les 
cultures mycobactériennes des crachats se sont révélés négatifs. On a 
réalisé un CXR chez 26 femmes symptomatiques ; chez trois d’entre 
elles, le cliché a suggéré une TB (miliaire 1, infiltrats 1 et creusement 
1). Sur les 149 femmes chez qui le dépistage des symptômes s’est 
avéré négatif, 100 ont subi un CXR et chez sept d’entre elles, le cliché 
a suggéré une TB (creusement 1, miliaire 2 et infiltrats 4). 
Conclusion  :  Cette étude ne soutient pas l’utilité d’un dépistage isolé 
des symptômes pour l’identification d’une maladie TB dans le contexte 
du PMTCT. Le CXR s’est révélé utile pour l’identification des suspects 
de TB tant chez les femmes symptomatiques qu’asymptomatiques. 
Objetivo: Determinar la utilidad diagnóstica de la evaluación siste-
mática de los síntomas de tuberculosis (TB) con el fin de detectar la 
TB activa en las mujeres infectadas por el virus de la inmunodefici-
encia humana (VIH) y embarazadas que acuden a dos consultorios de 
prevención de la transmisión maternoinfantil del VIH, financiados por 
la Alianza USAID–AMPATH en el occidente de Kenia.
Método: Fue este un estudio transversal, en el cual se administró a 
las participantes un cuestionario normalizado (tos de >2 semanas de 
duración, fiebre, sudores nocturnos y pérdida de peso o imposibilidad 
de ganar peso). Las mujeres que refirieron tos aportaron muestras de 
esputo para baciloscopia y cultivo de micobacterias. Se practicó una 
radiografía de tórax (CXR) protegida a las mujeres con más de 14 se-
manas de gestación. 
Resultados: En 38 de las 187 mujeres con infección por el VIH (20%), 
la detección de síntomas fue positiva. De estas mujeres, 21 refirieron 
tos de >2 semanas de evolución, pero todos los resultados de las ba-
ciloscopias y los cultivos de micobacterias fueron negativos. Se practi-
caron CXR en 26 mujeres sintomáticas y tres de ellas presentaron 
imágenes indicativas de TB (un aspecto miliar, un infiltrado y un caso 
con cavernas). De las 149 mujeres con una detección sintomática 
negativa, en 100 se practicó la CXR y siete presentaron imágenes en 
favor del diagnóstico de TB (un caso con cavernas, dos aspectos mi-
liares y cuatro con infiltrados). 
Conclusión: Los resultados del presente estudio no respaldan la utili-
dad de una detección exclusiva de los síntomas, con el fin de diag-
nosticar los casos de enfermedad TB en este contexto de la consulta 
de prevención de la transmisión maternoinfantil del VIH. La CXR se 
reveló útil en la detección de casos con presunción de TB en las mu-
jeres sintomáticas y asintomáticas. 